Strategies for repeat prostate biopsies

Urologists are routinely faced with the dilemma of a persistently worrisome clinical picture for prostate cancer in patients who have undergone prior negative ultrasound-guided prostate biopsies. Indications for repeat biopsy include sustained or worsening of the findings that prompted the initial biopsy; various derivations of prostate-specific antigen; and the histology from the initial biopsy (ie, high-grade prostatic intraepithelial neoplasia or atypical small acinar proliferation is identified). Large prostate volume or inflammation can confound the decision to perform repeat biopsies. Repeat biopsies should include a combination of standard sextant, lateral, anterior apical, and possibly transition zone biopsies. Repeat biopsies should consist of at least 14 cores but may include more than 36 samples. In patients who are not at high risk for prostate cancer, more than two sets of repeat biopsies have a very low yield.

• Publication year

  2009

• Venue

  Current Urology Reports

• Publication date

  2009-07-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S11934-009-0030-YPMID 19371473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Utility of percent free prostate-specific antigen in repeat prostate biopsy.

  2011cited by this paper
• Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy.

  2010cited by this paper
• Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer.

  2010cited by this paper
• Clinicopathological features of prostate cancers detected after an initial diagnosis of ‘atypical glands suspicious for cancer’

  2010cited by this paper
• Strategies for repeat prostate biopsies

  2009cited by this paper
• Reassessing the diagnostic yield of saturation biopsy of the prostate.

  2008cited by this paper
• Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies.

  2008cited by this paper
• Re: The Incidence of Fluoroquinolone Resistant Infections After Prostate Biopsy—Are Fluoroquinolones Still Effective Prophylaxis?

  2008cited by this paper
• The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?

  2008cited by this paper
• Prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.

  2008cited by this paper
• Prostate biopsy strategies

  2007cited by this paper
• The incidence of high‐grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first‐time saturation needle biopsy, and the subsequent risk of cancer

  2007influential reference
• Parasagittal biopsies are more important as part of an initial biopsy strategy than as part of a repeat biopsy strategy: observations from a unique population

  2007cited by this paper
• High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates.

  2007cited by this paper
• Improved prostate cancer detection with anterior apical prostate biopsies.

  2006cited by this paper
• Saturation technique does not improve cancer detection as an initial prostate biopsy strategy.

  2006cited by this paper
• Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience.

  2005cited by this paper
• Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study.

  2005cited by this paper
• Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.

  2004cited by this paper
• Update on prostate biopsy technique

  2004cited by this paper
• Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies.

  2004cited by this paper
• Determining variables for repeat prostate biopsy

  2004cited by this paper
• Influence of prostate volume in the detection of prostate cancer.

  2003cited by this paper
• Can total and transition zone volume of the prostate determine whether to perform a repeat biopsy?

  2003cited by this paper
• The utility of apical anterior horn biopsies in prostate cancer detection.

  2003cited by this paper
• The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection.

  2003cited by this paper
• Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy.

  2003cited by this paper
• Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

  2003cited by this paper
• Influence of prostate volume in the detection of prostate cancer.

  2003cited by this paper
• Significance of high-grade prostatic intraepithelial neoplasia on prostate biopsy.

  2003cited by this paper
• Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic cases.

  2002cited by this paper
• Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy.

  2002cited by this paper
• The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique.

  2002cited by this paper
• Prostate biopsy strategies: past, present, and future.

  2002cited by this paper
• Repeat prostate biopsy: who, how and when?. a review.

  2002influential reference
• Critical evaluation of the current indications for transition zone biopsies.

  2001cited by this paper
• Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study.

  2001cited by this paper
• Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk.

  2001cited by this paper
• Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.

  2001cited by this paper
• Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.

  2000cited by this paper
• Effect of Inflammation and Benign Prostatic Enlargement on Total and Percent Free Serum Prostatic Specific Antigen

  2000cited by this paper
• Strategy for repeat biopsy in patients with high grade prostatic intraepithelial neoplasia.

  2000cited by this paper
• Correlation of histological inflammation in needle biopsy specimens with serum prostate- specific antigen levels in men with negative biopsy for prostate cancer.

  2000cited by this paper
• Analysis of repeated biopsy results within 1 year after a noncancer diagnosis.

  2000influential reference
• The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial.

  2000cited by this paper
• A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy.

  2000cited by this paper
• Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer.

  1999cited by this paper
• Prostate cancer detection: relationship to prostate size.

  1999cited by this paper
• Surrogate Endpoint Biomarkers for Clinical Trials of Prostate Cancer Chemoprevention

  1999cited by this paper
• Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States.

  1998cited by this paper
• Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

  1998cited by this paper
• Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer.

  1998influential reference
• Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate.

  1997cited by this paper
• Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen.

  1996cited by this paper
• Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies.

  1996cited by this paper
• Repeat biopsy strategy in men with isolated prostatic intraepithelial neoplasia on prostate needle biopsy.

  1996cited by this paper
• Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels.

  1995cited by this paper
• Making the most out of six systematic sextant biopsies.

  1995cited by this paper
• Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia

  1994cited by this paper
• Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma.

  1993cited by this paper
• Transrectal ultrasound imaging and ultrasound guided prostate biopsies in the detection of residual carcinoma in clinical stage A carcinoma of the prostate.

  1992cited by this paper

• Feasibility study on a robot-assisted procedure for tumor localization using needle-rotation force signals

  2018cites this paper
• Transrectal ultrasound-guided prostate rebiopsy: How many core sampling should be applied to which patient?

  2018cites this paper
• The nomogram conundrum: a demonstration of why a prostate cancer risk model in Turkish men underestimates prostate cancer risk in the USA

  2016cites this paper
• Methylation in benign prostate and risk of disease progression in men subsequently diagnosed with prostate cancer

  2016cites this paper
• Multi-slice-to-volume registration for MRI-guided transperineal prostate biopsy

  2015cites this paper
• Patterns of repeat prostate biopsy in contemporary clinical practice.

  2015cites this paper
• Target localization in MRI-guided prostate biopsy

  2014cites this paper
• Accuracy analysis in MRI-guided robotic prostate biopsy

  2013cites this paper
• Development and Evaluation of an Actuated MRI-Compatible Robotic System for MRI-Guided Prostate Intervention

  2013cites this paper
• Optimising repeat prostate biopsy decisions and procedures

  2012cites this paper
• Is sampling transitional zone in patients who had prior negative prostate biopsy necessary?

  2012cites this paper
• Biopsy Needle Artifact Localization in MRI-Guided Robotic Transrectal Prostate Intervention

  2012cites this paper
• Prostate cancer detection after a negative prostate biopsy: Lessons learnt in the Cleveland Clinic experience

  2011cites this paper
• An MRI-Compatible Robotic System With Hybrid Tracking for MRI-Guided Prostate Intervention

  2011cites this paper